Conbercept

DB12460InvestigationalProtein Based Therapies

Conbercept has been investigated for the basic science of Age-related Macular Degeneration.

Mechanism: Pharmacologically active on Vascular endothelial growth factor A, long form, Placenta growth factor, and Vascular endothelial growth factor B
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

36Clinical trialsPhase, status and sponsor resolved per trial

15+ReferencesStructured and connected to the statements they support

Which drugs share a target with Conbercept, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.